Latest Breaking News On - Practice changing clinical trials - Page 1 : comparemela.com

EDAP Reports First Quarter 2024 Financial Results

EDAP TMS S A : Reports First Quarter 2024 Financial Results - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER .

EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting

         Final results demonstrate a significantly higher salvage treatment free survival rate  at 30 months of 89.6% in the HIFU-treated arm versus 86.2% in patients who.

Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, ...

- Phase 3 BOND-003 study results showed sustained, durable complete responses over 12 months with novel investigational oncolytic immunotherapy -

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

IRVINE, Calif., April 26, 2024 (GLOBE NEWSWIRE) CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients